Gender | Age | Cause of death | STI-1 immunoreactivity (no. of STI-1+ cells) | ||
---|---|---|---|---|---|
Human stroke patients | 1 | M | 54 | Fatal cerebral infarction (3 days after onset) | 3342 mm−2 |
2 | M | 57 | Fatal cerebral infarction (3 days after onset) | 3617 mm−2 | |
3 | F | 59 | Fatal cerebral infarction (1 day after onset) | 2543 mm−2 | |
4 | M | 61 | Fatal cerebral infarction (1 day after onset) | 2762 mm−2 | |
Control patients died of glioblastoma multiforme | 1 | M | 60 | Glioblastoma multiforme with brainstem failure | 27 mm−2 |
2 | F | 57 | Glioblastoma multiforme with brainstem failure | 31 mm−2 | |
3 | F | 61 | Glioblastoma multiforme with brainstem failure | 54 mm−2 | |
4 | M | 63 | Glioblastoma multiforme with brainstem failure | 49 mm−2 |
M, male; F, female; STI-1, stress-inducible protein 1.